Tagged with Singapore

Singapore Innovation is at the heart of healthcare transformation and the doors for a much-needed shift from provider- to patient-centric solutions have been opened. That is the idea behind HealthBeats™, a Remote Vitals Monitoring (“RVM”) subscription-based global platform. Aileen Lai, CEO & Founder, shares how the company aims not only to…

Singapore Simranjit Singh highlights Guardant Health’s role in the global precision oncology landscape and how the company leverages its proprietary blood tests, vast data sets, and advanced analytics across the huge AMEA region. Singh also touches on the significance of a recent US FDA approval for its comprehensive liquid biopsy and…

Singapore John Baby of home rehabilitation device start-up WO:EX outlines how his firm’s products differ from others on the market through their multifunctionality, its expansion plans in Asia and Australia, and the benefits of starting a medtech business in Singapore.   We are looking for partners who understand the complexity and…

Singapore Dr Varun Sethi outlines some of the most important trends in ASEAN healthcare today and how DKSH, as a historic business services provider, is adapting its offering to meet them.   Singapore has always been considered the bellwether of driving innovation in the region, which remains the case. In terms…

Singapore Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy, government funding towards innovative life sciences start-ups and spin-offs has dramatically increased. These companies have greater access to funds, both from state actors as well as via private equity and public listings, but barriers…

Singapore Annie Tan highlights the strategy she laid out to navigate the BMS Singapore, Thailand and Malaysia affiliates through the COVID-19 pandemic; the opportunities and challenges of integrating the Celgene portfolio into local BMS operations; and her aim to build the company into an oncology and haematology powerhouse in Southeast Asia…

Singapore Kenneth Tan has been President for Asia Pacific & Japan at cancer-focused medical device player Varian since February 2019. In a recent conversation with PharmaBoardroom, Tan shared how an early passion for healthcare has blossomed into an impressive global career in pharmaceuticals and MedTech, why a multidisciplinary, collaborative and patient-centric…

Singapore Professor Ng Huck Hui of A*Star’s Biomedical Research Council outlines the evolution of Singapore’s science and technology research and innovation ecosystem over the past 20 years and why the country is now focusing on translational science and building up enterprise.   During the past 20 years, we have built clusters…

Singapore Dr Piers Ingram, PhD, co-founder, and CEO of Singapore-based biotech Hummingbird Bioscience, shares his motivation for establishing the company in 2015, their proprietary Rational Antibody Discovery (RAD) technology platform, and rich pipeline of clinical assets in global development.   As we are able to now understand biological systems much better…

Asia-Pacific UPS APAC’s Bee Lim describes how the logistics giant responded to the unprecedented challenges thrown up by the COVID-19 pandemic, the trends that the pandemic has accelerated in the region, and the talent profiles that UPS is looking for to ensure future success.   The capabilities that we have built…

Singapore Cerecin’s Charles Stacey outlines the company’s progress in expanding its lead asset into migraine and infantile spasms, how its funding strategy has evolved, why Singapore is still a logical base, and how broader developments in the CNS landscape stand to benefit all stakeholders.   Moving to Singapore was a good…

Singapore Clarence Ngui describes how global orthopaedic product giant Zimmer Biomet has pivoted in APAC in response to the COVID-19 pandemic; how medical education needs differ across the vast APAC region; and the challenges that have kept him at Zimmer for over 24 years.   Asia Pacific as a region represents…